story of the week
Exenatide and Dapagliflozin Alone or in Combination and Kidney Function in Obese Patients With T2D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Exenatide Twice Daily and Dapagliflozin Alone and in Combination on Markers of Kidney Function in Obese Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Controlled Clinical Trial
Diabetes Obes Metab 2021 Apr 28;[EPub Ahead of Print], CC van Ruiten, AB van der Aart-van der Beek, RG IJzerman, M Nieuwdorp, K Hoogenberg, DH van Raalte, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.